BM TRINITAS PHARMA LIMITED

Company number 14759446 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BM TRINITAS PHARMA LIMITED - Analysis Report

Company Number: 14759446

Analysis Date: 2025-07-19 12:07 UTC

  1. Risk Rating: LOW
    BM TRINITAS PHARMA LIMITED is classified as a dormant company with no reported assets, liabilities, or financial activity. It is current with its statutory filings and holds no overdue accounts or confirmation statements. Given the absence of trading activity, immediate solvency, liquidity, or operational risks are minimal.

  2. Key Concerns:

  • Lack of operational activity: The company has filed dormant accounts with zero assets and liabilities, indicating it is not currently generating revenue or incurring expenses. This limits assessment of business viability.
  • No financial history or performance data: With incorporation in 2023 and dormant status, there is no financial track record to evaluate stability or growth potential.
  • Concentrated control: One individual holds 75-100% of shares and voting rights, which may concentrate decision-making and governance risk.
  1. Positive Indicators:
  • Compliance: The company is up-to-date with all statutory filings, including accounts and confirmation statements, with no overdue documents or penalties.
  • Clear governance structure: Three directors are appointed with one corporate secretary previously retained, suggesting formal governance arrangements are in place.
  • No liabilities or debts reported: The clean balance sheet reflects no immediate financial obligations or creditor risk.
  1. Due Diligence Notes:
  • Investigate the company’s business plan and timeline for commencing trading to understand future operational and financial prospects.
  • Verify the reason for dormant status and whether the company intends to remain inactive or start business activities soon.
  • Review the backgrounds and reputations of the directors and controlling shareholder to assess governance quality and potential risks.
  • Confirm there are no contingent liabilities or off-balance sheet arrangements not disclosed in the dormant accounts.
  • Monitor future filings for any changes in financial position or operational status.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.